Cargando…
Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?
The multicenter study conducted by Lorente and coworkers published in the previous issue of Critical Care demonstrates that matrix metalloproteinase (MMP)-9 and MMP-10 and their inhibitor tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) are promising novel biomarkers to predict severity and o...
Autores principales: | Hoffmann, Ursula, Brueckmann, Martina, Borggrefe, Martin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811909/ https://www.ncbi.nlm.nih.gov/pubmed/20017890 http://dx.doi.org/10.1186/cc8156 |
Ejemplares similares
-
New horizons: NT-proBNP for risk stratification of patients with shock in the intensive care unit
por: Hoffmann, Ursula, et al.
Publicado: (2006) -
Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2010) -
Alterations of leptin in the course of inflammation and severe sepsis
por: Behnes, Michael, et al.
Publicado: (2012) -
Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2009) -
Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment
por: Behnes, Michael, et al.
Publicado: (2014)